Report Detail

Medical Devices & Consumables Global 2019-nCoV Assay Kit Market Research Report 2021

  • RnM3946549
  • |
  • 23 March, 2021
  • |
  • Global
  • |
  • 132 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 2019-nCoV Assay Kit Market Overview

  • 1.1 Product Overview and Scope of 2019-nCoV Assay Kit
  • 1.2 2019-nCoV Assay Kit Segment by Type
    • 1.2.1 Global 2019-nCoV Assay Kit Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Nucleic Acid Detection Kit
    • 1.2.3 Antibody Detection Kit
  • 1.3 2019-nCoV Assay Kit Segment by Application
    • 1.3.1 2019-nCoV Assay Kit Sales Comparison by Application: (2021-2027)
    • 1.3.2 Designated Hospital
    • 1.3.3 Diagnostic Center
    • 1.3.4 Scientific Research
    • 1.3.5 Port of Entry
    • 1.3.6 Individual
    • 1.3.7 Others
  • 1.4 Global 2019-nCoV Assay Kit Market Size Estimates and Forecasts
    • 1.4.1 Global 2019-nCoV Assay Kit Revenue 2016-2027
    • 1.4.2 Global 2019-nCoV Assay Kit Sales 2016-2027
    • 1.4.3 2019-nCoV Assay Kit Market Size by Region: 2016 Versus 2021 Versus 2027

2 2019-nCoV Assay Kit Market Competition by Manufacturers

  • 2.1 Global 2019-nCoV Assay Kit Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global 2019-nCoV Assay Kit Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global 2019-nCoV Assay Kit Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers 2019-nCoV Assay Kit Manufacturing Sites, Area Served, Product Type
  • 2.5 2019-nCoV Assay Kit Market Competitive Situation and Trends
    • 2.5.1 2019-nCoV Assay Kit Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest 2019-nCoV Assay Kit Players Market Share by Revenue
    • 2.5.3 Global 2019-nCoV Assay Kit Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 2019-nCoV Assay Kit Retrospective Market Scenario by Region

  • 3.1 Global 2019-nCoV Assay Kit Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global 2019-nCoV Assay Kit Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America 2019-nCoV Assay Kit Market Facts & Figures by Country
    • 3.3.1 North America 2019-nCoV Assay Kit Sales by Country
    • 3.3.2 North America 2019-nCoV Assay Kit Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe 2019-nCoV Assay Kit Market Facts & Figures by Country
    • 3.4.1 Europe 2019-nCoV Assay Kit Sales by Country
    • 3.4.2 Europe 2019-nCoV Assay Kit Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific 2019-nCoV Assay Kit Market Facts & Figures by Region
    • 3.5.1 Asia Pacific 2019-nCoV Assay Kit Sales by Region
    • 3.5.2 Asia Pacific 2019-nCoV Assay Kit Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America 2019-nCoV Assay Kit Market Facts & Figures by Country
    • 3.6.1 Latin America 2019-nCoV Assay Kit Sales by Country
    • 3.6.2 Latin America 2019-nCoV Assay Kit Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa 2019-nCoV Assay Kit Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa 2019-nCoV Assay Kit Sales by Country
    • 3.7.2 Middle East and Africa 2019-nCoV Assay Kit Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global 2019-nCoV Assay Kit Historic Market Analysis by Type

  • 4.1 Global 2019-nCoV Assay Kit Sales Market Share by Type (2016-2021)
  • 4.2 Global 2019-nCoV Assay Kit Revenue Market Share by Type (2016-2021)
  • 4.3 Global 2019-nCoV Assay Kit Price by Type (2016-2021)

5 Global 2019-nCoV Assay Kit Historic Market Analysis by Application

  • 5.1 Global 2019-nCoV Assay Kit Sales Market Share by Application (2016-2021)
  • 5.2 Global 2019-nCoV Assay Kit Revenue Market Share by Application (2016-2021)
  • 5.3 Global 2019-nCoV Assay Kit Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Roche
    • 6.1.1 Roche Corporation Information
    • 6.1.2 Roche Description and Business Overview
    • 6.1.3 Roche 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Roche Product Portfolio
    • 6.1.5 Roche Recent Developments/Updates
  • 6.2 Seegene
    • 6.2.1 Seegene Corporation Information
    • 6.2.2 Seegene Description and Business Overview
    • 6.2.3 Seegene 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Seegene Product Portfolio
    • 6.2.5 Seegene Recent Developments/Updates
  • 6.3 PharmACT
    • 6.3.1 PharmACT Corporation Information
    • 6.3.2 PharmACT Description and Business Overview
    • 6.3.3 PharmACT 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 PharmACT Product Portfolio
    • 6.3.5 PharmACT Recent Developments/Updates
  • 6.4 Everlywell
    • 6.4.1 Everlywell Corporation Information
    • 6.4.2 Everlywell Description and Business Overview
    • 6.4.3 Everlywell 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Everlywell Product Portfolio
    • 6.4.5 Everlywell Recent Developments/Updates
  • 6.5 Biopanda
    • 6.5.1 Biopanda Corporation Information
    • 6.5.2 Biopanda Description and Business Overview
    • 6.5.3 Biopanda 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Biopanda Product Portfolio
    • 6.5.5 Biopanda Recent Developments/Updates
  • 6.6 Mylab Discovery
    • 6.6.1 Mylab Discovery Corporation Information
    • 6.6.2 Mylab Discovery Description and Business Overview
    • 6.6.3 Mylab Discovery 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Mylab Discovery Product Portfolio
    • 6.6.5 Mylab Discovery Recent Developments/Updates
  • 6.7 Integrated DNA Technologies
    • 6.6.1 Integrated DNA Technologies Corporation Information
    • 6.6.2 Integrated DNA Technologies Description and Business Overview
    • 6.6.3 Integrated DNA Technologies 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Integrated DNA Technologies Product Portfolio
    • 6.7.5 Integrated DNA Technologies Recent Developments/Updates
  • 6.8 Cosara Diagnostics
    • 6.8.1 Cosara Diagnostics Corporation Information
    • 6.8.2 Cosara Diagnostics Description and Business Overview
    • 6.8.3 Cosara Diagnostics 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Cosara Diagnostics Product Portfolio
    • 6.8.5 Cosara Diagnostics Recent Developments/Updates
  • 6.9 Solgent
    • 6.9.1 Solgent Corporation Information
    • 6.9.2 Solgent Description and Business Overview
    • 6.9.3 Solgent 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Solgent Product Portfolio
    • 6.9.5 Solgent Recent Developments/Updates
  • 6.10 Kogene Biotech
    • 6.10.1 Kogene Biotech Corporation Information
    • 6.10.2 Kogene Biotech Description and Business Overview
    • 6.10.3 Kogene Biotech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Kogene Biotech Product Portfolio
    • 6.10.5 Kogene Biotech Recent Developments/Updates
  • 6.11 SD Biosensor
    • 6.11.1 SD Biosensor Corporation Information
    • 6.11.2 SD Biosensor 2019-nCoV Assay Kit Description and Business Overview
    • 6.11.3 SD Biosensor 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 SD Biosensor Product Portfolio
    • 6.11.5 SD Biosensor Recent Developments/Updates
  • 6.12 Biosewoom
    • 6.12.1 Biosewoom Corporation Information
    • 6.12.2 Biosewoom 2019-nCoV Assay Kit Description and Business Overview
    • 6.12.3 Biosewoom 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Biosewoom Product Portfolio
    • 6.12.5 Biosewoom Recent Developments/Updates
  • 6.13 Shanghai ZJ Bio-Tech
    • 6.13.1 Shanghai ZJ Bio-Tech Corporation Information
    • 6.13.2 Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
    • 6.13.3 Shanghai ZJ Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Shanghai ZJ Bio-Tech Product Portfolio
    • 6.13.5 Shanghai ZJ Bio-Tech Recent Developments/Updates
  • 6.14 Shanghai Geneodx Biotech
    • 6.14.1 Shanghai Geneodx Biotech Corporation Information
    • 6.14.2 Shanghai Geneodx Biotech 2019-nCoV Assay Kit Description and Business Overview
    • 6.14.3 Shanghai Geneodx Biotech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 Shanghai Geneodx Biotech Product Portfolio
    • 6.14.5 Shanghai Geneodx Biotech Recent Developments/Updates
  • 6.15 INNOVITA
    • 6.15.1 INNOVITA Corporation Information
    • 6.15.2 INNOVITA 2019-nCoV Assay Kit Description and Business Overview
    • 6.15.3 INNOVITA 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 INNOVITA Product Portfolio
    • 6.15.5 INNOVITA Recent Developments/Updates
  • 6.16 Genomics Biotech (Wuhan)
    • 6.16.1 Genomics Biotech (Wuhan) Corporation Information
    • 6.16.2 Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Description and Business Overview
    • 6.16.3 Genomics Biotech (Wuhan) 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.16.4 Genomics Biotech (Wuhan) Product Portfolio
    • 6.16.5 Genomics Biotech (Wuhan) Recent Developments/Updates
  • 6.17 Zhongshan Daan Gene
    • 6.17.1 Zhongshan Daan Gene Corporation Information
    • 6.17.2 Zhongshan Daan Gene 2019-nCoV Assay Kit Description and Business Overview
    • 6.17.3 Zhongshan Daan Gene 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.17.4 Zhongshan Daan Gene Product Portfolio
    • 6.17.5 Zhongshan Daan Gene Recent Developments/Updates
  • 6.18 Sanaure
    • 6.18.1 Sanaure Corporation Information
    • 6.18.2 Sanaure 2019-nCoV Assay Kit Description and Business Overview
    • 6.18.3 Sanaure 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.18.4 Sanaure Product Portfolio
    • 6.18.5 Sanaure Recent Developments/Updates
  • 6.19 Shanghai Bio-Germ
    • 6.19.1 Shanghai Bio-Germ Corporation Information
    • 6.19.2 Shanghai Bio-Germ 2019-nCoV Assay Kit Description and Business Overview
    • 6.19.3 Shanghai Bio-Germ 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.19.4 Shanghai Bio-Germ Product Portfolio
    • 6.19.5 Shanghai Bio-Germ Recent Developments/Updates
  • 6.20 Guangzhou Wonfo Bio-Tech
    • 6.20.1 Guangzhou Wonfo Bio-Tech Corporation Information
    • 6.20.2 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
    • 6.20.3 Guangzhou Wonfo Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.20.4 Guangzhou Wonfo Bio-Tech Product Portfolio
    • 6.20.5 Guangzhou Wonfo Bio-Tech Recent Developments/Updates
  • 6.21 Chengdu Boaojing Bio-Tech
    • 6.21.1 Chengdu Boaojing Bio-Tech Corporation Information
    • 6.21.2 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
    • 6.21.3 Chengdu Boaojing Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.21.4 Chengdu Boaojing Bio-Tech Product Portfolio
    • 6.21.5 Chengdu Boaojing Bio-Tech Recent Developments/Updates
  • 6.22 Beijing XABT
    • 6.22.1 Beijing XABT Corporation Information
    • 6.22.2 Beijing XABT 2019-nCoV Assay Kit Description and Business Overview
    • 6.22.3 Beijing XABT 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.22.4 Beijing XABT Product Portfolio
    • 6.22.5 Beijing XABT Recent Developments/Updates
  • 6.23 Bioscience(Chongqing) Bio-Tech
    • 6.23.1 Bioscience(Chongqing) Bio-Tech Corporation Information
    • 6.23.2 Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
    • 6.23.3 Bioscience(Chongqing) Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.23.4 Bioscience(Chongqing) Bio-Tech Product Portfolio
    • 6.23.5 Bioscience(Chongqing) Bio-Tech Recent Developments/Updates
  • 6.24 Maccura Bio-Tech
    • 6.24.1 Maccura Bio-Tech Corporation Information
    • 6.24.2 Maccura Bio-Tech 2019-nCoV Assay Kit Description and Business Overview
    • 6.24.3 Maccura Bio-Tech 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.24.4 Maccura Bio-Tech Product Portfolio
    • 6.24.5 Maccura Bio-Tech Recent Developments/Updates
  • 6.25 Xiamen InnoDx
    • 6.25.1 Xiamen InnoDx Corporation Information
    • 6.25.2 Xiamen InnoDx 2019-nCoV Assay Kit Description and Business Overview
    • 6.25.3 Xiamen InnoDx 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.25.4 Xiamen InnoDx Product Portfolio
    • 6.25.5 Xiamen InnoDx Recent Developments/Updates
  • 6.26 Guangdong Hecin-Scientific
    • 6.26.1 Guangdong Hecin-Scientific Corporation Information
    • 6.26.2 Guangdong Hecin-Scientific 2019-nCoV Assay Kit Description and Business Overview
    • 6.26.3 Guangdong Hecin-Scientific 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.26.4 Guangdong Hecin-Scientific Product Portfolio
    • 6.26.5 Guangdong Hecin-Scientific Recent Developments/Updates
  • 6.27 Wuhan Easydiagnosis Biomedicine
    • 6.27.1 Wuhan Easydiagnosis Biomedicine Corporation Information
    • 6.27.2 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Description and Business Overview
    • 6.27.3 Wuhan Easydiagnosis Biomedicine 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.27.4 Wuhan Easydiagnosis Biomedicine Product Portfolio
    • 6.27.5 Wuhan Easydiagnosis Biomedicine Recent Developments/Updates
  • 6.28 Curative
    • 6.28.1 Curative Corporation Information
    • 6.28.2 Curative 2019-nCoV Assay Kit Description and Business Overview
    • 6.28.3 Curative 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.28.4 Curative Product Portfolio
    • 6.28.5 Curative Recent Developments/Updates
  • 6.29 Biolidics
    • 6.29.1 Biolidics Corporation Information
    • 6.29.2 Biolidics 2019-nCoV Assay Kit Description and Business Overview
    • 6.29.3 Biolidics 2019-nCoV Assay Kit Sales, Revenue and Gross Margin (2016-2021)
    • 6.29.4 Biolidics Product Portfolio
    • 6.29.5 Biolidics Recent Developments/Updates

7 2019-nCoV Assay Kit Manufacturing Cost Analysis

  • 7.1 2019-nCoV Assay Kit Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of 2019-nCoV Assay Kit
  • 7.4 2019-nCoV Assay Kit Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 2019-nCoV Assay Kit Distributors List
  • 8.3 2019-nCoV Assay Kit Customers

9 2019-nCoV Assay Kit Market Dynamics

  • 9.1 2019-nCoV Assay Kit Industry Trends
  • 9.2 2019-nCoV Assay Kit Growth Drivers
  • 9.3 2019-nCoV Assay Kit Market Challenges
  • 9.4 2019-nCoV Assay Kit Market Restraints

10 Global Market Forecast

  • 10.1 2019-nCoV Assay Kit Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Type (2022-2027)
  • 10.2 2019-nCoV Assay Kit Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Application (2022-2027)
  • 10.3 2019-nCoV Assay Kit Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of 2019-nCoV Assay Kit by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of 2019-nCoV Assay Kit by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Nucleic Acid Detection Kit
    Antibody Detection Kit

    Segment by Application
    Designated Hospital
    Diagnostic Center
    Scientific Research
    Port of Entry
    Individual
    Others

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Roche
    Seegene
    PharmACT
    Everlywell
    Biopanda
    Mylab Discovery
    Integrated DNA Technologies
    Cosara Diagnostics
    Solgent
    Kogene Biotech
    SD Biosensor
    Biosewoom
    Shanghai ZJ Bio-Tech
    Shanghai Geneodx Biotech
    INNOVITA
    Genomics Biotech (Wuhan)
    Zhongshan Daan Gene
    Sanaure
    Shanghai Bio-Germ
    Guangzhou Wonfo Bio-Tech
    Chengdu Boaojing Bio-Tech
    Beijing XABT
    Bioscience(Chongqing) Bio-Tech
    Maccura Bio-Tech
    Xiamen InnoDx
    Guangdong Hecin-Scientific
    Wuhan Easydiagnosis Biomedicine
    Curative
    Biolidics


    Summary:
    Get latest Market Research Reports on 2019-nCoV Assay Kit. Industry analysis & Market Report on 2019-nCoV Assay Kit is a syndicated market report, published as Global 2019-nCoV Assay Kit Market Research Report 2021. It is complete Research Study and Industry Analysis of 2019-nCoV Assay Kit market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,056.10
    3,084.15
    4,112.20
    2,389.60
    3,584.40
    4,779.20
    316,709.00
    475,063.50
    633,418.00
    213,121.00
    319,681.50
    426,242.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report